TABLE 1.
Demographic and BAL cell differentials for study subjectsa
| Subject group (no.) | Age (yr) | No. male | No. HIV+ | No. of smokers | BAL | BAL cell differential (%)
|
||
|---|---|---|---|---|---|---|---|---|
| AM | L | PMN | ||||||
| Healthy (7) | 30 ± 2 | 5 | 0 | 3 | 95 | 4 | 1 | |
| TB (10) | 44 ± 5 | 9 | 1 | 2 | IN | 55 | 20 | 24 |
| UN | 90 | 8 | 2 | |||||
| TB receiving IFN-γ (10) | 42 ± 4 | 10 | 2 | 5 | Pre IN | 70 | 25 | 5 |
| Pre UN | 86 | 12 | 2 | |||||
| Post IN | 72 | 22 | 6 | |||||
| Post UN | 80 | 15 | 5 | |||||
| TB with second BAL (1) | 45 | 1 | 0 | 0 | Pre | 84 | 15 | 1 |
| Post | 91 | 9 | 0 | |||||
a
Values shown are means ± SEM. AM, alveolar macrophages; L, lymphocytes; PMN, neutrophils; IN, involved lobe; UN, uninvolved lobe; Pre, BAL samples obtained before treatment; Post, BAL samples obtained 1 month into treatment.